Flavonoid Market Projected to Reach $2.9 Billion by 2032

The global market for flavonoids, a class of naturally occurring plant compounds known for their antioxidant properties and potential health benefits, is projected to reach $2.9 billion by 2032. Allied Market Research reported that the market was valued at $1.7 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2023 to 2032.

Key drivers for market expansion include increasing consumer awareness regarding the health benefits of flavonoids, particularly when used as dietary supplements. Furthermore, the inherent advantages of flavonoids in pharmaceutical applications for treating chronic diseases such as cancer and cardiovascular conditions are contributing to demand.

The aging global population is expected to create significant opportunities for the cosmetics industry, which in turn will boost flavonoid demand. In pharmaceuticals, the polyphenolic structure of flavonoids is utilized for its antioxidant and various pharmacological activities in treating a range of diseases.

Recent trends, including a heightened focus on health and immunity following the COVID-19 pandemic, have increased consumer interest in wellness products. The growing preference for clean-label products, emphasizing natural ingredients over synthetic additives, also supports the growth of the flavonoid market.